Earnings Releases·Nov 2, 2026, 4:10 PM ET

SI-BONE, Inc. — Third Quarter 2026 Earnings Summary

Worldwide revenue grew 14.5% year-over-year to $55.7 million, while net loss narrowed 20.7% to $3.6 million and Adjusted EBITDA improved 32.4% to a positive $3.0 million.
The company reaffirmed 2026 revenue guidance of $231–$233 million and gross margin of ~79.0%, while updating operating expense growth expectations downward to 10.5% from 12.0%.
U.S. procedure volume increased 19.5% and active physicians grew 16% to 1,770, supported by new MS-DRG reimbursement increases and the alpha launch of the iFuse Granite Onyx device.
Management projects positive full-year Adjusted EBITDA for 2026 and anticipates entering 2027 with a strong foundation for growth acceleration.